Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Autoimmunity. 2014 Nov 20;48(4):222–230. doi: 10.3109/08916934.2014.984836

Table 3.

Percentage of cells in the spinal cords of SJL/J female mice at the peak of the 2nd EAE attack.

Cell populationa NT (%) Acthar (%) Placebo gel (%)
CD45+ total 57.5 ± 3.9 39.4 ± 15.4 54.7 ± 11.9
CD45+ CD3+ 78.6 ± 4.3 86.9 ± 2.2 85.2 ± 2.6
CD45+ CD3+ CD4+ 55.6 ± 6.1 40.3 ± 6.8 59.4 ± 0.9
CD45+ CD19+ 0.146 ± 0.1 0.1 ± 0.1 0.3 ± 0.2
R1 18.0 ± 2.9 50.6 ± 18.7 17.6 ± 1.7
R2 32.5 ± 1.2 19.3 ± 9.6 22.4 ± 3.1
R1/R2 0.55 2.62 0.79
a

Cell populations were gated on 7-AAD negative (viable) cells.

NT no treatment.

Spinal cord cells from to 2–3 mice/group were pooled for a total of three pooled groups for each treatment.

Data represent the mean ± SEM.